Last update: Feb. 1, 2017
Minimal risk for breastfeeding and infant.
Anticholinergic drug used as spasmolytic for functional gastrointestinal disorders.
At latest update relevant published data on excretion into breast milk were not found.
It acts locally on the intestinal mucosa. Absorption through the intestine is practically absent (Evangelista 2004, Catalogo 2008), with an excretion being almost 100% unmodified in feces that is determinant for the extremely low levels reached in the plasma (Zhao 2010: <0.02 mg / L), which causes the passage through breastmilk in significant amounts must be very unlikely.
Side effects are mild and very rarely seen.
Although anticholinergics may reduce milk production, however, because of its poor absorption it would not be the case with Otilonium.
We do not have alternatives for Otilonium Bromide since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM